Enhanced Clinical Outcomes and Treatment Adherence in Patients Using Compounded Topical Minoxidil to Treat Androgenetic and Traction Alopecia
August 2025
in “
PubMed
”
Studysummary This study found that compounded topical minoxidil was associated with higher adherence, fewer side effects, and more clinical improvement in Black women compared to over-the-counter minoxidil. Our plain-language summary of this paper — not a Tressless recommendation.
This study evaluated the effectiveness and adherence of compounded topical minoxidil (CTM) in treating androgenetic and traction alopecia in 66 Black women at Johns Hopkins Hospital. The CTM formulation included a steroid and retinoid, and was compared to over-the-counter (OTC) minoxidil. Results showed that 69.6% of patients using CTM reported clinical improvement, compared to 45.0% with OTC minoxidil. Additionally, CTM had a higher adherence rate of 84.7% versus 44.7% for OTC minoxidil, and fewer side effects were reported with CTM. The study suggests that CTM may be more effective and better tolerated than OTC minoxidil for this patient group.